Together, these studies offer valuable new evidence supporting the use of GLP-1 receptor agonists for kidney and cardiovascular protection in individuals at risk for or with established chronic kidney disease
For decades, this trend seemed to be insurmountable contributing to an obesity pandemic that places an enormous burden on our collective health due to obesitys association with various conditions including type 2 diabetes, cardiovascular disease, metabolic dysfunction-associated steatotic liver disease (MASLD), and certain types of cancer to name just a few [2]
Potassium What it does General Potassium is an essential mineral that helps maintain fluid and electrolyte balance, influences blood pressure, and is required for proper nerve conduction and muscle contraction
Saxenda, Enobosarm, VK2735, TERN-601, and ECC5004, among others GLP-1 agonists are a type of medication used primarily in the treatment of type 2 diabetes and sometimes for weight management